Patients: Intraperitoneal chemotherapy ‘worth it’ for ovarian cancer
WASHINGTON – Intraperitoneal chemotherapy may be unpleasant and interfere with daily life, but the large majority of women who received it for ovarian cancer agreed that it was the right choice for...
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Family Practices | Ovarian Cancer | Ovaries | Primary Care | Women